US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Parabilis Medicines

39.47

+0.46001.18%

Post-market: 39.470.00000.00%16:44 EDT

Volume:500.17K

Turnover:19.41M

Market Cap:4.89B

PE:-1.68

High:40.00

Open:39.15

Low:37.88

Close:39.01

52wk High:41.49

52wk Low:24.51

Shares:124.00M

Float Shares:33.50M

Volume Ratio:1.26

T/O Rate:1.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-23.4458

EPS(LYR):-60.0402

ROE:--

ROA:--

PB:4.67

PE(LYR):-0.66

Loading ...

Overview Company News Filings

Parabilis Medicines to Raise $745 Million in IPO, Private Offering

MT Newswires Live

Parabilis Medicines, a Rising Star in Cancer Peptide Therapy, Prices IPO Above Range with 10x Oversubscription, Raising $745 Million

Parabilis Medicines 33.5M share IPO priced at $20.00

Parabilis Medicines Announces Pricing of Upsized Initial Public Offering

Parabilis Medicines Boosts IPO to 33.3 Million Shares From 25 Million

Biotech Firm Parabilis Aims for $4.5 Billion IPO on Nasdaq with $2.6 Billion Valuation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/PBLS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBLS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","market":"US","secType":"STK","nameCN":"Parabilis Medicines","latestPrice":39.47,"timestamp":1788292800000,"preClose":39.01,"halted":0,"volume":500167,"hourTrading":{"tag":"盘后","latestPrice":39.47,"preClose":39.47,"latestTime":"16:44 EDT","volume":503,"amount":19856.589966000003,"timestamp":1788295451716,"change":0,"changeRate":0,"amplitude":0.013428},"delay":0,"changeRate":0.011791848244040013,"floatShares":33500000,"shares":124000000,"eps":-23.44581,"marketStatus":"Post-Mkt","change":0.46,"latestTime":"09-01 17:31:04 EDT","open":39.15,"high":40,"low":37.88,"amount":19411604.311081998,"amplitude":0.054345,"askPrice":40,"askSize":1,"bidPrice":38,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-23.44581,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"listingDate":1781064000000,"exchange":"NASDAQ","adjPreClose":39.01,"preHourTrading":{"tag":"盘前","latestPrice":38.01,"preClose":39.01,"latestTime":"09:06 EDT","volume":23,"amount":900.719928,"timestamp":1788267979579,"change":-1,"changeRate":-0.025634,"amplitude":0.039221},"postHourTrading":{"tag":"盘后","latestPrice":39.47,"preClose":39.47,"latestTime":"16:44 EDT","volume":503,"amount":19856.589966000003,"timestamp":1788295451716,"change":0,"changeRate":0,"amplitude":0.013428},"volumeRatio":1.258546,"impliedVol":0.4768,"impliedVolPercentile":0.1212},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","floatShares":33500000,"roa":"--","roe":"--","lyrEps":-60.040199,"volumeRatio":1.258546,"shares":124000000,"dividePrice":0,"high":40,"amplitude":0.054345,"preClose":39.01,"low":37.88,"week52Low":24.51,"pbRate":"4.67","psRate":"33069.46","week52High":41.4899,"institutionHeld":0,"latestPrice":39.47,"committee":0.980198,"eps":-23.44581,"divideRate":0,"volume":500167,"delay":0,"ttmEps":-23.44581,"open":39.15,"prevYearClose":20,"prevWeekClose":39.11,"prevMonthClose":39.01,"prevQuarterClose":27.37,"fiveDayClose":39.23,"twentyDayClose":35.9,"sixtyDayClose":20},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBLS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PBLS","fiscalQuarterEnding":"2026/06","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBLS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBLS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1786939200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBLS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBLS","date":"2026-08-31","current":-1.683456,"percent":0.272727,"low":-31.159897,"twenty":-28.505108,"median":-25.67089,"eighty":-22.938881,"high":-15.535256,"avg":-25.814203,"sd":2.99884,"marketCap":4831385016},"quantilePoints":[{"date":"2026-06-12","current":-23.423744,"twenty":-24.021896,"median":-23.423744,"eighty":-18.690651,"marketCap":3580998591},{"date":"2026-06-18","current":-21.681158,"twenty":-23.280127,"median":-22.147598,"eighty":-21.001488,"marketCap":3314593719},{"date":"2026-06-26","current":-21.956025,"twenty":-22.933884,"median":-22.426629,"eighty":-21.561216,"marketCap":3356615076},{"date":"2026-07-02","current":-23.122126,"twenty":-23.423744,"median":-22.77646,"eighty":-21.681158,"marketCap":3534887500},{"date":"2026-07-10","current":-25.287743,"twenty":-24.420664,"median":-22.938881,"eighty":-21.956025,"marketCap":3865964860},{"date":"2026-07-17","current":-24.204934,"twenty":-24.912925,"median":-23.706058,"eighty":-22.147598,"marketCap":3700426180},{"date":"2026-07-24","current":-27.328421,"twenty":-25.279414,"median":-24.204934,"eighty":-22.705661,"marketCap":4177941603},{"date":"2026-07-31","current":-26.886968,"twenty":-25.665893,"median":-24.321545,"eighty":-22.738979,"marketCap":4110452756},{"date":"2026-08-07","current":-29.635636,"twenty":-26.527142,"median":-24.625564,"eighty":-22.753971,"marketCap":4530666328},{"date":"2026-08-14","current":-29.710599,"twenty":-28.289622,"median":-24.912925,"eighty":-22.788954,"marketCap":4542126698},{"date":"2026-08-21","current":-28.671719,"twenty":-28.53843,"median":-25.283578,"eighty":-22.890572,"marketCap":4889445639},{"date":"2026-08-28","current":-28.461644,"twenty":-28.506557,"median":-25.662561,"eighty":-22.933884,"marketCap":4853620999},{"date":"2026-08-31","current":-28.331252,"twenty":-28.505108,"median":-25.67089,"eighty":-22.938881,"marketCap":4831385016}],"updateTime":1788298264355},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBLS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642944754","title":"Parabilis Medicines to Raise $745 Million in IPO, Private Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2642944754","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642944754?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:03","pubTimestamp":1781085823,"startTime":"0","endTime":"0","summary":"Parabilis Medicines has priced an upsized initial public offering of 33.5 million shares at $20 per share, the company said Tuesday.Underwriters have been granted a 30-day option to purchase up to abo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PBLS","LU2106854487.HKD","LU2237438978.USD","LU0823416689.USD","LU0114720955.EUR","LU2023250504.SGD","LU2362541513.USD","BK4588","LU2362540622.SGD","BK4585","LU0053666078.USD","LU0320765992.SGD","LU0882574055.USD","LU1917777945.USD","REGN","LU0109394709.USD","LU0823434740.USD","IPOS","LU0289739699.SGD","LU2468319806.SGD","LU1974910355.USD","LU0058720904.USD","BK4139","LU2362541273.HKD","LU2089984988.USD","LU0823434583.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198122444","title":"Parabilis Medicines, a Rising Star in Cancer Peptide Therapy, Prices IPO Above Range with 10x Oversubscription, Raising $745 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1198122444","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198122444?lang=en_us&edition=fundamental","pubTime":"2026-06-10 11:40","pubTimestamp":1781062844,"startTime":"0","endTime":"0","summary":"A U.S. biotechnology company focused on cancer treatments, Parabilis Medicines (PBLS.US), has completed an upsized U.S. IPO priced above its marketed range. Combined with a concurrent private...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642167419","title":"Parabilis Medicines 33.5M share IPO priced at $20.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2642167419","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642167419?lang=en_us&edition=fundamental","pubTime":"2026-06-10 09:35","pubTimestamp":1781055318,"startTime":"0","endTime":"0","summary":"The deal size was increased to 33.5M shares and priced above the $17.00-$19.00 target range. Leerink, BofA, Evercore ISI, Guggenheim and LifeSci Ca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/parabilis-medicines-33-5m-share-ipo-priced-at-20-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/parabilis-medicines-33-5m-share-ipo-priced-at-20-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPOS","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642415198","title":"Parabilis Medicines Announces Pricing of Upsized Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2642415198","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642415198?lang=en_us&edition=fundamental","pubTime":"2026-06-10 08:22","pubTimestamp":1781050920,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., June  09, 2026  (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addre","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/10/3309413/0/en/Parabilis-Medicines-Announces-Pricing-of-Upsized-Initial-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642246192","title":"Parabilis Medicines Boosts IPO to 33.3 Million Shares From 25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2642246192","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642246192?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:32","pubTimestamp":1781001120,"startTime":"0","endTime":"0","summary":"Parabilis Medicines has increased the size of a planned initial public offering that could give the clinical-stage biopharmaceutical company an initial market capitalization topping $2 billion.Parabilis on Tuesday said it now plans to sell more than 33.3 million shares at between $17 and $19 each in the IPO, up from prior plans to offer 25 million shares.At the $18 midpoint of that price range, the Cambridge, Mass., company said it expects net proceeds of about $553.1 million, or around $636.8 million if the underwriters exercise an option to buy an additional 5 million shares.Parabilis said it would have about 123.8 million shares outstanding after the IPO and a $75 million private placement with collaboration partner Regeneron Pharmaceuticals, assuming an exercise of the overallotment option, for a market capitalization of nearly $2.23 billion at the $18-a-share pricing midpoint.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189601949","title":"Biotech Firm Parabilis Aims for $4.5 Billion IPO on Nasdaq with $2.6 Billion Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=1189601949","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189601949?lang=en_us&edition=fundamental","pubTime":"2026-06-04 16:52","pubTimestamp":1780563136,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology company Parabilis Medicines has set terms for a $450 million initial public offering in the United States.The firm, which focuses on developing engineered peptide...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":46,"code":"91000000","status":"200"}]}}